BIOMAT Database Logo BIOMAT Database Logo

Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors. 2019

Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Dipartimento di Scienze chimiche, biologiche, farmaceutiche ed ambientali, Università di Messina, Via S.S. Annunziata, 98168 Messina, Italy. robromeo@unime.it.

The pyrimidine nucleus is a versatile core in the development of antiretroviral agents. On this basis, a series of pyrimidine-2,4-diones linked to an isoxazolidine nucleus have been synthesized and tested as nucleoside analogs, endowed with potential anti-HIV (human immunodeficiency virus) activity. Compounds 6a-c, characterized by the presence of an ethereal group at C-3, show HIV reverse transcriptase (RT) inhibitor activity in the nanomolar range as well as HIV-infection inhibitor activity in the low micromolar with no toxicity. In the same context, compound 7b shows only a negligible inhibition of RT HIV.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase.
January 2011, ACS medicinal chemistry letters,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Anti-HIV agents: design and discovery of new potent RT inhibitors.
March 2003, Farmaco (Societa chimica italiana : 1989),
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Synthesis, Herbicidal Activity, and QSAR of Novel N-Benzothiazolyl- pyrimidine-2,4-diones as Protoporphyrinogen Oxidase Inhibitors.
January 2016, Journal of agricultural and food chemistry,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Design, synthesis and anticancer evaluation of selective 2,4-disubstituted pyrimidine CDK9 inhibitors.
December 2022, European journal of medicinal chemistry,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
December 2017, European journal of medicinal chemistry,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Anticonvulsant properties of selected pyrrolo[2,3-d]pyrimidine-2,4-diones and intermediates.
April 1980, Journal of pharmaceutical sciences,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Design, synthesis and herbicidal activity of novel quinazoline-2,4-diones as 4-hydroxyphenylpyruvate dioxygenase inhibitors.
August 2015, Pest management science,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
March 2016, Journal of medicinal chemistry,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.
April 2011, Bioorganic & medicinal chemistry letters,
Roberto Romeo, and Daniela Iannazzo, and Lucia Veltri, and Bartolo Gabriele, and Beatrice Macchi, and Caterina Frezza, and Francesca Marino-Merlo, and Salvatore V Giofrè
Synthesis of new thieno [2,3-d]pyrimidine-2,4(1H,3H)-diones with analgesic and anti-inflammatory activities.
February 1998, Arzneimittel-Forschung,
Copied contents to your clipboard!